2016-2020 World Infectious Disease Testing Market: Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts for 100 Tests, Innovative Technologies, Instrumentation Review
Complete report $34,500.DataPack (test volumes, sales forecasts, supplier shares) $21,100. This comprehensive seven-country report contains 1,954 pages, 824 tables, and is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies. The report provides market segmentation analysis of over 100 diseases and viruses in seven countries; assessment of emerging technologies; review of current instrumentation; as well as strategic profiles of leading suppliers and recent market entrants with innovative technologies and products.Infectious Diseases Analyzed in the Report AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia. Geographic Coverage
- France
- Germany
- Italy
- Japan
- Spain
- UK
- US
- Sales and market shares of major suppliers of infectious disease diagnostic products, by country and individual test.
- Test and sales forecasts for over 90 infectious disease diagnostic assays by country, individual test and market segment:
- Hospitals
- Blood Banks
- Commercial/Private Laboratories
- Physician Offices/Group Practices
- Public Health Laboratories
- Review of market dynamics, trends, structure, size, growth and major suppliers by country.
- In-depth examination of over 90 major diseases, including etiology, current diagnostic tests, vaccines, drugs and market needs.
- Review of major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices.
- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for infectious disease testing.
- Extensive listings of companies developing or marketing infectious disease diagnostic products worldwide by individual test.Competitive Assessments
- Detailed strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.
- Estimated universe of laboratories performing infectious disease testing by country.
- Test volume and sales projections for major infectious disease diagnostic assays by country.
- Emerging opportunities for new instrumentation, reagents, IT and other products with significant market appeal during the next five years.
- Design criteria for decentralized testing products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
282
